Fundraising Fox

Lungpacer Medical

Exton, US · Founded 2009 · 58 employees on LinkedIn · 2 known investors

Lungpacer Medical develops neurostimulation technologies for critical care, focused on ventilator weaning to improve outcomes for patients. Its offerings are built by a team of clinical and engineering experts.

Deep TechHardwareHealthtechMedical Devices

Founders & leadership

DG
Douglas G. EvansChief Executive Officer and President
VT
Viral ThakkarinCOO
RD
Rosemarie DhavaleChief Financial Officer and Vice President of HR
SK
Shannon KaustinenDirector of Finance
DE
Doug EvansinPresident and CEO
KK
Kevin KearneyinCCO
SP
Steven PfanstielinCFO

Board

JP
Jan PensaertBoard director
BD
Bob DonohueBoard director
GD
Guillaume DarnandBoard director
CK
Christopher KipleChair of the Board
JW
Joseph W. KaufmannBoard director

Investors · 2

Keiretsu ForumSan Francisco · $250K – $2M
New Enterprise Associates (NEA)Menlo Park · $200K – $40M

Reported raises · per SEC filings

Form D private placements

$137.4M disclosed across 6 rounds · 2017–2026

▶$16MraisedJul 2026 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas G. EvansExecutive Officer, Director
  • Joseph W. KaufmannDirector
  • Bob DonohueDirector
  • Christopher KipleExecutive Officer
  • Jan PensaertDirector
  • Jonathan ConlinExecutive Officer
  • Steven E. PfanstielExecutive Officer
  • Viral ThakkarExecutive Officer
Offering amount
$20M
Amount sold
$16M
First sale
Apr 2026
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedApr 2025 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jan PensaertDirector
  • Jonathan ConlinExecutive Officer
  • Bob DonohueDirector
  • Douglas G. EvansExecutive Officer, Director
  • Viral ThakkarExecutive Officer
  • Rosemarie DhavaleExecutive Officer
  • Christopher KipleExecutive Officer, Director
  • Joseph W. KaufmannDirector
Offering amount
$10M
Amount sold
$10M
First sale
Mar 2025
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16MraisedDec 2022 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph KaufmannDirector
  • Josh MakowerDirector
  • Jose Calle GordoDirector
  • Karen LongDirector
  • Christopher KipleExecutive Officer, Director
  • Douglas G. EvansExecutive Officer, Director
  • Jonathan ConlinExecutive Officer
  • Bob DonohueDirector
  • Nawzer MehtaExecutive Officer
  • Rosemarie DhavaleExecutive Officer
Offering amount
$21.1M
Amount sold
$16M
First sale
Dec 2020
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedApr 2022 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Josh MakowerDirector
  • Chris KipleExecutive Officer, Director
  • Valeska SchroederDirector
  • Rosemarie DhavaleExecutive Officer
  • Lesley FronioExecutive Officer
  • Douglas G. EvansExecutive Officer, Director
  • Jonathan ConlinExecutive Officer
  • Joseph W. KaufmannDirector
  • Bob DonohueDirector
  • Jose Calle GordoDirector
  • Nawzer MehtaExecutive Officer
Offering amount
$30M
Amount sold
$20M
First sale
Apr 2022
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$55.8MraisedMay 2019 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan ConlinExecutive Officer
  • Josh MakowerDirector
  • Guillaume DarnandDirector
  • Michael FavetDirector
  • Joseph W. KaufmannDirector
  • Douglas EvansExecutive Officer, Director
Offering amount
$65M
Amount sold
$55.8M
First sale
Apr 2019
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$19.6MraisedJun 2017 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas EvansExecutive Officer, Director
  • Shannon KaustinenExecutive Officer, Director
  • Michael L. FavetDirector
  • Guillaume DarnandDirector
Offering amount
$19.6M
Amount sold
$19.6M
Proceeds to insiders
$173.5K
First sale
May 2017
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap
Rf Surgical12 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Synapse Biomedical Inc.12 shared keywordsSynapse Biomedical develops and commercializes neurostimulation medical devices, including the NeuRx Diaphragm Pacing System (DPS), which uses electrical stimulation of the diaphragm to treat chronic respiratory insufficiency in patients with spinal cord injuries and ALS. The company serves clinicians and patients dependent on mechanical ventilation.
Oup11 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.

Companies competing with Lungpacer Medical for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Lungpacer Medical do?
Lungpacer Medical develops neurostimulation technologies for critical care, focused on ventilator weaning to improve outcomes for patients. Its offerings are built by a team of clinical and engineering experts.
Who are Lungpacer Medical's investors?
Lungpacer Medical's investors include Keiretsu Forum, New Enterprise Associates (NEA).
How much funding has Lungpacer Medical raised?
Lungpacer Medical has disclosed $137.4M raised across 6 rounds.
Where is Lungpacer Medical headquartered?
Lungpacer Medical is headquartered in Exton, US.